Things categorized as 'Venture Capital'
Lycera Closes $36 Million Series A
Lycera announced the closing of a $36M Series A round of funding. The company is developing novel small-molecule pharmaceuticals to treat autoimmune diseases such as ...
Synageva Nets $30M
Synageva BioPharma announced the first closing of a financing raising $30 million. The round was led by Baker Brothers Investments. Other investors participating in the ...
Proteon Therapeutics Has A Big Day
Proteon Therapeutics announced it has successfully completed a $38 million Series B equity financing, started a Phase 1/2 clinical trial with its lead product, PRT-201, ...
Heptares Secures $30M in Series A Funding
Heptares Therapeutics, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), annnouced it has raised $30M (GBP21M) of equity finance in a successful ...
Symphogen Nets $44M in Financing
The Copenhagen based Symphogen announced the closing of a € 33 million (approximately U.S. $44 million) financing. Existing investors participated in the round, ...
Hydra Biosciences Raises $22 Million in Series D Financing
Hydra Biosciences raised $22.2 million in a Series D financing led by MedImmune Ventures, a wholly-owned venture capital fund of MedImmune, the biologics business of ...
Kolltan Raises over $35 Million in Series A Haul
Kolltan Pharmaceuticals, which in my opinion sounds like the name of a cartoon villian, has raised over $35 million in its Series A preferred stock ...
Vivaldi Biosciences Nets $23M in Series A Round
Vivaldi Biosciences, developing live attenuated vaccines for influenza, announced that it has received commitments for $23 million in a Series A Read More →
Anaphore Announces $25 Million Series A Financing
Anaphore announced it has raised $25 million in Series A financing led by 5AM Ventures, Versant Ventures, and Apposite Capital. Not a bad haul for ...
Intradigm Closes Final Tranche of $21.4 Million Series B Financing
Intradigm announced that the company has closed the final tranche of its Series B financing. Astellas Venture Management led the $2.9 million tranche, with existing ...
Catalyst Biosciences Raises $40 Million in Series C Financing
Catalyst Biosciences has raised $40.4 million in a Series C financing round. New investor Essex Woodlands Health Ventures led the round, with participation from existing ...
Numerate Completes $4 Million Series A
Numerate, a biotechnology company leveraging a novel drug engineering process to design lead-stage drug compounds, announced today that it has completed a $4 million Series ...
Zafgen Raises $14 Million in Series B
ZafGen, a Cambridge-based developer of an obesity therapy based on the vascular targeting of adipose tissue, has raised $14 million in Series B funding, according ...
Pacira Pharmaceuticals Raises $85 Million in Series A
Pacira Pharmaceuticals, a San Diego based maker of controlled-release injectable products, has expanded its Series A round to $85 ...
Accera Completes $35 Million Series C Financing
Accera announced it has recently closed a Series C financing round of $35 million (euro 27 million), led by Inventages Venture Capital SA. The company ...